Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05874843 · ClinicalTrials.gov registry record · NA
Validation of Point-of-care Thromboelastography (TEG 6s) in Pediatric Patients
A NA study of Coagulopathy, sponsored by Indiana University.
- Recruiting
- Registry status
- NA
- Development phase
- 125
- Enrollment target
- 1
- Study location
NCT05874843 is a NA study of Coagulopathy that is actively recruiting participants, run by Indiana University. The registered enrollment target is 125 participants. The trial reports 1 study location across 1 state.
The verdict
NCT05874843, a NA study of Coagulopathy, is actively recruiting participants, sponsored by Indiana University.
- RECRUITING
- Registry status
- NA
- Development phase
- 125 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this observational study is to learn about the performance of the TEG6s in normal pediatric patients. The main questions it aims to answer are: What are the normal TEG 6S lab results in normal pediatric patients and how do they compare to existing published reference ranges. Participants and their guardians will be asked to submit a small amount of blood at the beginning of an elective operation for analysis in the TEG 6s machine.
Conditions Studied
Interventions
- DIAGNOSTIC_TEST Thromboelastography (TEG 6S)
Study Locations (1)
Indiana
- Riley Hospital for Children - Indianapolis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 125 participants |
| Start Date | 2023-09-11 |
| Est. Completion | 2026-12-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05874843
The ClinicalTrials.gov registry entry for NCT05874843 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 125 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Indiana University, which has 890 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Coagulopathy appearing as the primary indexed condition, and to 1 intervention - of which Thromboelastography (TEG 6S) is the first listed.
NCT05874843 reports 1 study location spanning 1 distinct geographic area - top geographies include Indiana.
Frequently Asked Questions
What is clinical trial NCT05874843 about?
NCT05874843 is a clinical study titled "Validation of Point-of-care Thromboelastography (TEG 6s) in Pediatric Patients". The goal of this observational study is to learn about the performance of the TEG6s in normal pediatric patients. The main questions it aims to answer are: What are the normal TEG 6S lab results in normal pediatric patients and how do they compare to existing published reference ranges. Participants...
What is the current status of trial NCT05874843?
This trial is currently recruiting. It is a NA study. The enrollment target is 125 participants. The study started on 2023-09-11. Estimated completion is 2026-12-01.
What conditions does trial NCT05874843 study?
This clinical trial studies the following conditions: Coagulopathy.
What interventions are being tested in trial NCT05874843?
The interventions under investigation include: Thromboelastography (TEG 6S) (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT05874843?
This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05874843 being conducted?
This trial has 1 study location across Indiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.